| Schedule of Basic and Diluted Net Income (Loss) Per Share |
The components of basic and diluted net income (loss) per share were as follows: | | | Three months ended September 30, | | | Nine months ended September 30, | | | (In thousands, except share and per share data) | | 2026 | | | 2025 | | | 2026 | | | 2025 | | | Numerator: | | | | | | | | | | | | | | Net (loss) income from continuing operations | | $ | (533 | ) | | $ | (10,633 | ) | | $ | 20,573 | | | $ | (21,112 | ) | | Net (loss) income from discontinued operations | | | — | | | | (32 | ) | | | — | | | | 1,461 | | | Minus: net income (loss) allocated to participating warrants | | | — | | | | — | | | | (14,264 | ) | | | — | | | Numerator for basic EPS - Net (loss) income available for common shareholders | | $ | (533 | ) | | $ | (10,665 | ) | | $ | 6,309 | | | $ | (19,651 | ) | | | | | | | | | | | | | | | | | | | | Effect of dilutive securities | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Interest expense on Convertible Notes - from continuing operations | | $ | — | | | $ | — | | | $ | 4,440 | | | $ | — | | | Change in fair value of liability-classified warrants | | | — | | | | — | | | | (12 | ) | | | — | | | Reallocation of net income to participating warrants | | | — | | | | — | | | | 152 | | | | — | | | Numerator for diluted EPS - Net (loss) income available for common shareholders | | $ | (533 | ) | | $ | (10,665 | ) | | $ | 10,889 | | | $ | (19,651 | ) | | | | | | | | | | | | | | | | | | | | Denominator: | | | | | | | | | | | | | | | | | | Denominator for basic EPS - Weighted-average common shares outstanding | | | 7,722,524 | | | | 2,002,568 | | | | 4,029,540 | | | | 1,973,553 | | | Effect of dilutive securities | | | | | | | | | | | | | | | | | | Unvested restricted stock units | | | — | | | | — | | | | — | | | | — | | | Liability-classified warrants | | | — | | | | — | | | | 32,106 | | | | — | | | Conversion of Convertible Notes | | | — | | | | — | | | | 2,947,143 | | | | — | | | Denominator for diluted EPS - adjusted weighted-average common stock outstanding | | | 7,722,524 | | | | 2,002,568 | | | | 7,008,789 | | | | 1,973,553 | | | Basic net (loss) income per share attributable to common shareholders | | $ | (0.07 | ) | | $ | (5.33 | ) | | $ | 1.57 | | | $ | (9.96 | ) | | Diluted net (loss) income per share attributable to common shareholders | | $ | (0.07 | ) | | $ | (5.33 | ) | | $ | 1.55 | | | $ | (9.96 | ) |
|
| Schedule of Anti-Dilutive Shares |
the Company excluded the following potential common stock equivalents, presented based on amounts outstanding at each period end, from the computation of diluted earnings (loss) per share attributable to common stockholders for the periods presented because their inclusion would have been anti-dilutive. | | | Nine months ended September 30, | | | | | 2026 | | | 2025 | | | Shares subject to outstanding warrants | | | 7,708 | | | | 7,641,863 | | | Shares subject to unvested restricted stock units | | | 124,750 | | | | 82,000 | | | Shares subject to outstanding stock options | | | 75 | | | | 75 | | | | | | 132,533 | | | | 7,723,938 | |
|